The stock of Bristol-Myers Squibb Co (NYSE:BMY) last traded at $55.83, up 0.07% from the previous session.
BMY stock price is now -2.18% away from the 50-day moving average and 10.25% away from the 200-day moving average. The market capitalization of the company currently stands at $113.30B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target maintained at $70, Jefferies recently Upgraded its rating from Hold to Buy for Bristol-Myers Squibb Co (NYSE: BMY)., while ‘Wolfe Research’ rates the stock as ‘Peer Perform’
In other news, BOERNER CHRISTOPHER S., Chief Executive Officer bought 2,000 shares of the company’s stock on Feb 20 ’25. The stock was bought for $110,096 at an average price of $55.05. Upon completion of the transaction, the Chief Executive Officer now directly owns 104,626 shares in the company, valued at $5.84 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 14 ’25, EVP,Chief Med.Offr.,Drug Dev. Hirawat Samit bought 1,823 shares of the business’s stock. A total of $100,000 was incurred on buying the stock at an average price of $54.84. This leaves the insider owning 63,932 shares of the company worth $3.57 million. A total of 0.12% of the company’s stock is owned by insiders.
During the past 12 months, Bristol-Myers Squibb Co has had a low of $39.35 and a high of $61.10. As of last week, the company has a debt-to-equity ratio of 3.13, a current ratio of 1.25, and a quick ratio of 1.15.
The net profit margin was -18.53% and return on equity was -39.10% for BMY. The company reported revenue of $12.34 billion for the quarter, compared to $11.48 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 7.54 percent.
